Stock listing

A0LGJ2 Stock Price, News, Filings & Events — Genfit Sa

Selected listing: A0LGJ2 · LS · EUR · DE

A0LGJ2:LS is the public stock listing for Genfit Sa, a biopharmaceutical company focused on developing innovative therapies for metabolic diseases, particularly non-alcoholic steatohepatitis (NASH). The company is actively engaged in clinical trials and research to advance its product pipeline, with recent updates highlighting progress in its drug development programs. Investors can find relevant news, regulatory filings, and upcoming events that may impact the company's performance and market position. Genfit Sa continues to navigate the competitive landscape of the biopharmaceutical industry, aiming to address significant unmet medical needs.

A0LGJ2:LSEURDEUpdated July 24, 2026
Genfit Sa logo
Ticker
A0LGJ2:LS
Asset type
Stock
Market cap
$757.2M
Sector
Health Technology
Industry
Biotechnology
Exchange
LS
Currency
EUR

Genfit Sa A0LGJ2:LS stock context

A0LGJ2:LS is the public stock listing for Genfit Sa, a biopharmaceutical company focused on developing innovative therapies for metabolic diseases, particularly non-alcoholic steatohepatitis (NASH). The company is actively engaged in clinical trials and research to advance its product pipeline, with recent updates highlighting progress in its drug development programs. Investors can find relevant news, regulatory filings, and upcoming events that may impact the company's performance and market position. Genfit Sa continues to navigate the competitive landscape of the biopharmaceutical industry, aiming to address significant unmet medical needs.

Research Genfit Sa

Alternate listings